BioMérieux H1 FY26 net income rises 40.6% to €226 million; net sales fall 3.9% to €1.97 billion

Reuters2026/07/28 05:10

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

BioMérieux posted H1 2026 net income (group share) of EUR 226 million, up 40.6%, as net sales fell 3.9% to EUR 1.97 billion.
Contributive operating income before non-recurring items dropped 15.7% to EUR 313 million, cutting its margin by 2.3 percentage points to 15.9%.
Free cash flow climbed 75.8% to EUR 299 million; net cash position more than doubled to EUR 236 million.
Q2 net sales rose 3.7% to EUR 981 million; BIOFIRE sales slipped 1.2% to EUR 339 million while SPOTFIRE sales rose 36.6% to EUR 34.3 million.
It reaffirmed 2026 guidance for organic sales growth of 3%-5% and organic CEBIT growth of 0%-10%, while cutting its 2027-2028 organic sales growth target to 3%-6%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioMérieux SA published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

BioMérieux H1 FY26 net income rises 40.6% to €226 million; net sales fall 3.9% to €1.97 billion

You may also like

Crypto prices